AI Change Control Impact Assessment Template
Overview
This AI Change Control Impact Assessment Template provides a structured, ready-to-use format for evaluating changes to AI systems operating in GMP-regulated environments. It helps teams determine how proposed updates may affect the validated state, regulatory obligations, risk profile, and required testing before approval.
Who Is This For?
- Change Control Coordinators
- QA professionals
- Validation Engineers
- IT Systems Owners
- Regulatory Compliance teams
Use Cases
- AI system upgrades and version changes
- Algorithm modifications impact assessment
- Training data changes evaluation
- Integration changes with GMP systems
- Periodic review of AI system performance
Download
The template is available in both editable Word format and PDF for printing or reference.
Key Benefits
- Structured evaluation: Guides teams through a consistent framework for reviewing planned AI-related changes
- Risk-based: Supports GMP-aligned classification of changes based on quality, safety, and compliance impact
- Validation-focused: Helps identify validation impact comprehensively before implementation
- Compliance-aware: Surfaces potential regulatory gaps and notification considerations early
- Decision-ready: Supports clear, documented justification for approval, rejection, or escalation
What the Template Covers
- Change classification and categorization
- Impact on validated state assessment
- Risk evaluation (patient safety, product quality, data integrity)
- Regulatory notification requirements
- Validation and testing requirements
- Rollback and contingency planning
Related Articles
- AI and Change Control Risk Assessment
- AI for Change Control Impact Assessments
- AI for Pharmaceutical Risk Management Under ICH Q9
- Computer System Validation for AI Software
- Validating AI Systems in Pharma
Disclaimer
This template is provided for educational and informational purposes only. It does not constitute regulatory advice, legal guidance, or a validated quality system document. Organizations should adapt this template to their specific regulatory requirements, quality management systems, and internal SOPs. Always consult with qualified regulatory and quality professionals before making compliance decisions.